- Reliable - Detect presence of SARS-CoV-2 RNA using our highly optimized AMPIPROBE® technology
- High-throughput - on GENFLEX™ automated platform for Molecular testing (sample processing, amplification and detection).
- Affordable - Low-cost alternative to other methods of viral load detection
- EUA authorized
The AMPIPROBE® SARS-CoV-2 RT-PCR Kit is a multiplexed assay that contain two primer/probe sets specific to different SARS- CoV-2 genomic regions and primers/probes for internal control and negative control, human RNase P. This kit is intended to be used in combination with the AMPIXTRACT™ SARS-CoV-2 Extraction Kit (Prod. No. ENZ-GEN216).
This kit can be used on Enzo's GENFLEX® platform (please contact us for more information). The GENFLEX® platform executes all of the liquid handling including the extraction of RNA and setting up of PCR reactions. This also ensures safe and reproducible handling of potentially infectious samples. As alternative, the RT-PCR can be performed on the QS5 RT-PCR instrument (Thermo Scientific).
Please contact us if you are considering the use of alternative qPCR instruments.
Product Details
Alternative Name: | Coronavirus (COVID-19) |
|
Applications: | qPCR
|
|
Application Notes: | Detection of SARS-CoV-2 RNA by RT-qPCR |
|
Shipping: | Dry Ice |
|
Long Term Storage: | -20°C |
|
Contents: | AMPIPROBE® RT-PCR Enzyme Mix
AMPIPROBE® RT-PCR Buffer
AMPIPROBE® SARS-CoV-2 Primer/Probe Mix
Nuclease-free Water |
|
Technical Info/Product Notes: | SARS-CoV-2 Test System - Fact Sheet for Healthcare Providers SARS-CoV-2 Test System - Fact Sheet for Patients |
|
Regulatory Status: | EUA - Emergency Use Authorization Only, IVD - For In vitro Diagnostic Use Only, Rx Only - For Prescription Use Only |
|
Disclaimer: |
- This test has not been FDA cleared or approved;
- This test has been authorized by FDA under an EUA for use by authorized laboratories;
- This test has been authorized only for the detection of nucleic acid from SARS-CoV-2, not for any other viruses or pathogens;
- This test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.
|
|
Related Products